期刊文献+

丹瓜方对转基因糖尿病小鼠心脏损伤的作用

Study of Dan Gua-Fang in Preventention and Treatment of Heart Injury of Genetically Induced Diabetic Mice
下载PDF
导出
摘要 探讨丹瓜方对转基因糖尿病小鼠心脏组织的影响。32只ApoE-/-小鼠数字随机等分为模型组、丹瓜方组、联合用药组(丹瓜方+吡格列酮)、吡格列酮组。喂以普通饲料,各组分别给药12周。小鼠处死,取心脏、匀浆,免疫组化测心脏血清反应因子(SRF)含量;解剖冠状动脉,光镜观察比较。结果:与模型组比较,联合用药组与丹瓜方组SRF阳性率降低有显著性差异(P<0.01);形态学观察,丹瓜方组与联合用药组冠状动脉内膜大部分无增厚。结果表明:丹瓜方对糖尿病小鼠心脏具有保护作用。 To observe the effect of D an Gua-Fang on the heart of genetically induced diabetic mice. T hirty-tw o A poE-/-diabetic m ice w ere random ly divided into the m odel group, D an-gua prescription group, the com bined treatm ent group (Dan-gua prescription+ pioglitazone) and pioglitazone group. E ach group w as given m edicine respectively, and fed w ith norm al diet for 12 w eeks. T he heart hom ogenates production w as used to m easure related indicators. T he expression of SR F in heart hom ogenates w as detected by im m unohistochem ical. T he C oronary w as observed under light m icroscopy. C om pared w ith the m odel group, there w ere significant difference of SR F positive rate betw een com bination group and D an-gua prescription group (P&lt;0.01). T he m orphology of D an-gua prescription group and the com bination group w as significantly im proved: m ost of the tunica intim a of the coronary artery cannot be found thickening. C om pared w ith the control group, Pioglitazone group&#39;s effect is w eaker,butbetterthan thatofthe untreated group.D an G ua-Fang hasprotective effecton the heartofdiabetic m ice.
出处 《莆田学院学报》 2014年第5期11-14,21,共5页 Journal of putian University
基金 福建省科技重点项目(2014Y0063) 福建省自然科学基金项目(2012J01392)
关键词 丹瓜方 转基因 糖尿病 冠状动脉 心脏 SR F D an G ua-Fang transgene diabetes coronary artery SR F heart
  • 相关文献

参考文献9

二级参考文献95

  • 1叶山东.氧化应激与糖尿病并发症[J].国外医学(内分泌学分册),1994,14(3):128-131. 被引量:21
  • 2兰菲菲,刘誉,陈万群,周羽竝,王丽娟,李琳娜.白毛藤提取物对肝癌SMMC-7721细胞增殖及c-myc基因表达的抑制作用[J].广东医学,2006,27(12):1779-1782. 被引量:12
  • 3李红霞,满永,国汉邦,唐蔚青,夏永静,董军,王抒,李健斋.北京市部分人群血压、血糖、血脂异常的知晓率、治疗率和达标率的调查[J].北京医学,2007,29(1):57-57. 被引量:17
  • 4ADVANCE COLLABORATIVE GROUP,PATEL A,MACMAHUN S,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358 (24):2560-2572.
  • 5ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP,GERSTEIN H C,MILLER M E,et al.Effects of intensive glucose lowering in type 2 diabetes[J].N Engl J Med,2008,358(24):2545-2559.
  • 6KOTSEVA K,STAGMO M,DE BACQUER D,et al.Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries:findings from the EUROASPIRE II survey[J].Atherosclerosis,2008,197(2):710-717.
  • 7REAVEN PD,EMANUELE N,MORITZ T,et al.Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT)[J].Diabetes Care,2008,31(5):952-957.
  • 8XIAN-PEI H,KE-JI C,ZHENG-FENG H,et al.Glucose endothelial cytotoxieity and protection by Dan Gua-Fang,a chinese herb prescription in huVEC in hyperglycemia medium[J].J Diabetes Complications,2008,Jul 25.[Epub ahead of print]
  • 9SHAI I,STAMPFER M J,MA J,et al.Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers,lipids and dietary factors[J].Atherosclerosis,2004,177(2):375-381.
  • 10MYLIWIEC M,BALCEBSKA A,ZORENA K,et al.The assessment of the correlation between vascular endothelial growth factor (VEGF),tumor necrosis factor (TNF-alpha),intedeukin 6 (IL-6),glycaemic control (HbAlc) and the development of the diahetic retinopathy in children with diabetes mellitus type 1[J].Klin Oczna,2007,109(4-6):150-154.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部